Vanguard Group Inc Catalyst Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 8,431,094 shares of CPRX stock, worth $182 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,431,094

Previous 8,040,978 4.85%

Holding current value

$182 Million

Previous $160 Million 10.07%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$19.73 - $23.93 $7.7 Million - $9.34 Million	390,116 Added 4.85%	8,431,094 $176 Million
Q3 2024 Nov 13, 2024	SELL	$15.19 - $21.35 $901,936 - $1.27 Million	-59,377 Reduced 0.73%	8,040,978 $160 Million
Q2 2024 Aug 13, 2024	BUY	$14.68 - $16.92 $1.76 Million - $2.03 Million	119,694 Added 1.5%	8,100,355 $125 Million
Q1 2024 May 10, 2024	BUY	$13.18 - $17.11 $11.3 Million - $14.7 Million	860,244 Added 12.08%	7,980,661 $127 Million
Q4 2023 Feb 14, 2024	BUY	$11.78 - $17.29 $870,895 - $1.28 Million	73,930 Added 1.05%	7,120,417 $120 Million
Q3 2023 Nov 14, 2023	BUY	$11.69 - $15.02 $2.04 Million - $2.62 Million	174,739 Added 2.54%	7,046,487 $82.4 Million
Q2 2023 Aug 14, 2023	SELL	$11.5 - $18.08 $629,027 - $988,939	-54,698 Reduced 0.79%	6,871,748 $92.4 Million
Q1 2023 May 15, 2023	BUY	$14.34 - $21.05 $2.26 Million - $3.32 Million	157,705 Added 2.33%	6,926,446 $115 Million
Q4 2022 Feb 10, 2023	BUY	$12.25 - $19.5 $7.71 Million - $12.3 Million	629,091 Added 10.25%	6,768,741 $126 Million
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $9.02 Million - $19.8 Million	1,277,662 Added 26.28%	6,139,650 $78.8 Million
Q2 2022 Aug 12, 2022	BUY	$6.23 - $8.57 $799,832 - $1.1 Million	128,384 Added 2.71%	4,861,988 $34.1 Million
Q1 2022 May 13, 2022	SELL	$5.31 - $8.31 $545,384 - $853,511	-102,709 Reduced 2.12%	4,733,604 $39.2 Million
Q4 2021 Feb 14, 2022	SELL	$5.21 - $7.45 $310,203 - $443,573	-59,540 Reduced 1.22%	4,836,313 $32.7 Million
Q3 2021 Nov 12, 2021	SELL	$4.85 - $6.04 $438,289 - $545,828	-90,369 Reduced 1.81%	4,895,853 $25.9 Million
Q2 2021 Aug 13, 2021	BUY	$4.29 - $6.05 $21.4 Million - $30.2 Million	4,986,222 New	4,986,222 $28.7 Million

Others Institutions Holding CPRX

# of Institutions

345

Shares Held

98.4M

Call Options Held

13.4K

Put Options Held

11.7K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.22B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Catalyst Pharmaceuticals, Inc. Transaction History